Pergoveris FD and Liquid China BE Study
Clinical trial NCT04899193 · COMPLETED
Trial details
- NCT number
- NCT04899193
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-08
- Primary completion
- 2022-05-28
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.